Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-668-5 | CAS number: 999-97-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- chronic toxicity: inhalation
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data waiving: Data from handbook or collection of data
Data source
Reference
- Title:
- SIAM 29, 20-22 October 2009, SIDS INITIAL ASSESSMENT PROFILE
Materials and methods
Results and discussion
Applicant's summary and conclusion
- Conclusions:
- The repeated-dose toxicity of HMDZ has been investigated by the inhalation route in a combined repeated-dose/ reproductive/developmental toxicity screening study (OECD TG 422). The test article was administered to groups of 10 rats/sex via whole-body vapour inhalation for six hours/day, seven days/week to target concentrations of 0 (filtered air), 25, 100 and 400 ppm (0.16, 0.66, and 2.66 mg/L). Males were exposed throughout the 15 day pre-mating period and during the mating and post-mating periods, for a total of at least 4 weeks. Females were exposed throughout the pre-mating and mating periods and during pregnancy and lactation, until day 4 post-partum (or until sacrifice for un-mated females). Un-mated females were used in the repeated-dose portion of the study. Clinical signs were consistent with nervous system effects immediately after exposure at 2.66 mg/L. Significantly decreased body weight [15%] and food consumption were observed at 2.66 mg/L and absolute body weights of 0.66 mg/L females were decreased [7%; p<0.02]. Effects on haematology and serum chemistry parameters were noted at 2.66 mg/L. Decreases in absolute epididymides weight of 2.66 mg/L males and absolute lung weights of 2.66 mg/L females were observed. Increases in relative kidney weight were observed at 0.66 and 2.66 mg/L (females) and 2.66 mg/L (males). Increased relative liver weight was observed in 2.66 mg/L females. Centrilobular hypertrophy in the liver of 2.66 mg/L females was the only microscopic finding. Based on the clinical observations, body weight changes, serum chemistry, haematology and histological findings following whole body inhalation exposure, the systemic toxicity NOAEC was 0.66 mg/L and the LOAEC was 2.66 mg/L. .
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
